PepGen (PEPG) Operating Expenses (2021 - 2026)
PepGen (PEPG) posted Operating Expenses of $18.9 million for Q1 2026, down 3.87% sequentially from $19.7 million in Q4 2025, and down 39.52% YoY from $31.3 million in Q1 2025.
Analysis
PepGen (PEPG) Operating Expenses (2021 - 2026) Analysis & Trends
PepGen has reported Operating Expenses for 6 years, with the latest figure at $18.9 million in Q1 2026.
- Quarterly Operating Expenses fell 39.52% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.2 million (down 25.65% YoY) and the FY2025 annual result came in at $93.6 million, down 4.22% from the prior year.
- Operating Expenses retreated to $18.9 million in Q1 2026 per PEPG's latest filing, from $19.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $31.3 million in Q1 2025 and troughed at $13.9 million in Q1 2022.
- A 5-year average of $21.4 million and a median of $19.8 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses jumped 239.77% in 2022, then sank 39.52% in 2026.
- Over 5 years, Operating Expenses stood at $17.2 million in 2022, then advanced by 20.9% to $20.8 million in 2023, then rose by 16.98% to $24.3 million in 2024, then fell by 19.06% to $19.7 million in 2025, then slipped by 3.87% to $18.9 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $18.9 million, $19.7 million, and $18.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.05 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 960.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 505.13 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.21 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 541.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 427.03 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 18.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.94 Mn |
| Mar 31, 2026 | 18.94 Mn |
| Dec 31, 2025 | 19.71 Mn |
| Sep 30, 2025 | 18.65 Mn |
| Jun 30, 2025 | 23.93 Mn |
| Mar 31, 2025 | 31.32 Mn |
| Dec 31, 2024 | 24.35 Mn |
| Sep 30, 2024 | 23.17 Mn |
| Jun 30, 2024 | 30.43 Mn |
| Mar 31, 2024 | 19.80 Mn |
| Dec 31, 2023 | 20.81 Mn |
| Sep 30, 2023 | 24.78 Mn |
| Jun 30, 2023 | 21.14 Mn |
| Mar 31, 2023 | 18.03 Mn |
| Dec 31, 2022 | 17.21 Mn |
| Sep 30, 2022 | 19.55 Mn |
| Jun 30, 2022 | 17.64 Mn |
| Mar 31, 2022 | 13.89 Mn |
| Dec 31, 2021 | 7.21 Mn |
| Sep 30, 2021 | 8.08 Mn |